Inclusive of all taxes
ETHAMSIG 500 TAB by BluepillExpress, under the Dr Precision label, is a pharmaceutical-grade hemostatic tablet containing 500 mg of Ethamsylate. This high-strength formulation is specifically designed to control and prevent capillary bleeding across various medical indications such as menorrhagia, epistaxis, post-surgical bleeding, hematuria, and intracranial hemorrhages, including neonatal periventricular and intraventricular hemorrhages. Unlike hormonal or anticoagulant therapies, ETHAMSIG 500 TAB acts by stabilizing capillary endothelial resistance, promoting platelet adhesion, and stimulating thromboplastin formation without interfering with coagulation pathways, ensuring safety for patients with clotting disorders or those on anticoagulants. Its quick onset of action—within 1 to 2 hours when taken orally, and faster via IV/IM administration—makes it highly effective in emergency and preventive care environments such as hospitals, clinics, and specialized medical setups. Manufactured under GMP standards, this tablet is ideal for bulk supply, private labeling, and export to regulated and semi-regulated global markets, making it a reliable choice for healthcare providers requiring an efficacious, targeted hemostatic solution.
Key Features
| Features | Description |
|---|---|
| Active Ingredient | Ethamsylate 500 mg |
| Therapeutic Action | Capillary bleeding control and hemostasis promotion |
| Indications | Menorrhagia, epistaxis, post-operative bleeding, hematuria, postpartum hemorrhage, neonatal intracranial hemorrhages |
| Mechanism of Action | Increases capillary endothelial resistance, enhances platelet aggregation and adhesion, reduces prostaglandin synthesis, stimulates thromboplastin formation |
| Onset of Action | 1–2 hours oral; 5–15 minutes IV/IM |
| Safety Profile | Non-hormonal, non-steroidal; does not affect coagulation or fibrinolysis |
| Manufacturing Standards | GMP-compliant under Dr Precision label |
| Pharmacokinetics | 70–90% oral bioavailability; peak plasma within 4 hours; half-life 2–3 hours; renal excretion |
| Suitable For | Hospitals, clinics, surgical centers, emergency care, gynecological and pediatric use |
| Marketing & Supply | Available for bulk manufacturing, private labeling, and export |
| Attributes | Description |
|---|---|
| Dosage Form | Tablet |
| Dosage Strength | 500 mg Ethamsylate |
| Manufacturer | BluepillExpress |
| Brand Label | Dr Precision |
| Regulatory Compliance | GMP-certified production |
| Route of Administration | Oral; injectable forms for IV/IM available |
| Shelf Life | As per manufacturer guidelines |
| Storage Conditions | Store in a cool, dry place away from direct sunlight |
| Packaging | Bulk packaging options with private labeling available |
| Therapeutic Category | Hemostatic Agent |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
ETHAMSIG 500 TAB contains Ethamsylate, a non-hormonal agent that stabilizes capillary resistance and enhances platelet function without hormonal side effects, making it safer for patients who cannot tolerate hormonal therapies.
Yes, ETHAMSIG 500 TAB does not interfere with the coagulation cascade or fibrinolysis, making it safe to use alongside anticoagulant medications.
With a rapid onset of action—1 to 2 hours orally and as fast as 5-15 minutes via IV/IM—ETHAMSIG 500 TAB quickly promotes clot formation and capillary stability, crucial in managing acute bleeding episodes.
Yes, the product is indicated for use in periventricular and intraventricular hemorrhages in neonates, providing targeted hemostatic support without disrupting coagulation.
Dr Precision ensures that ETHAMSIG 500 TAB is produced under stringent GMP-compliant processes, guaranteeing pharmaceutical-grade quality, purity, and formulation precision suitable for global distribution.
Country Of Origin: India
ETHAMSIG 500 TAB is a high-strength hemostatic tablet containing Ethamsylate 500 mg, formulated to control capillary bleeding in various medical conditions, including menorrhagia, epistaxis, post-surgical bleeding, and intracranial hemorrhage. Manufactured by BluepillExpress, this product is trusted globally for its anti-hemorrhagic and vascular stabilizing action, making it a reliable option for hospitals, clinics, and emergency medical care settings. BluepillExpress offers this formulation for bulk manufacturing, private labeling, and export markets across regulated and semi-regulated zones.
This product is manufactured under the Dr Precision label, ensuring GMP-compliant quality and precision formulation standards.
ETHAMSIG 500 TAB, offered by BluepillExpress, is a high-quality, pharmaceutical-grade Ethamsylate 500 mg tablet used to manage and prevent various forms of bleeding caused by fragile blood vessels or platelet disorders. Ethamsylate is a non-hormonal, non-steroidal hemostatic agent that enhances capillary stability, improves platelet adhesion, and reduces bleeding time without affecting the coagulation cascade.
This medication plays a vital role in reducing abnormal bleeding from small vessels and is used in both emergency and preventive scenarios in gynecology, surgery, ENT, ophthalmology, and general medicine. With a rapid onset of action, ETHAMSIG 500 TAB promotes hemostasis without the risks associated with hormonal or anticoagulant therapies.
✅ Therapeutic Indications
Menorrhagia (heavy menstrual bleeding)
Post-operative bleeding (e.g., dental surgery, ENT, gynecologic procedures)
Epistaxis (nosebleeds)
Hematuria
Periventricular and intraventricular hemorrhage in neonates
Postpartum hemorrhage
Bleeding due to platelet dysfunction or capillary fragility
✅ Mechanism of Action
Ethamsylate works by:
Increasing capillary endothelial resistance, preventing rupture
Enhancing platelet aggregation and adhesion to damaged blood vessel walls
Reducing prostaglandin synthesis, which decreases bleeding
Stimulating thromboplastin formation at the injury site for faster clot formation
It does not affect coagulation time or fibrinolysis, making it safe for patients with clotting disorders or those on anticoagulants.
✅ Pharmacokinetics
Onset of Action: 1–2 hours (oral), 5–15 minutes (IV/IM)
Bioavailability: ~70–90% orally
Peak Plasma Levels: Within 4 hours
Half-life: 2–3 hours
Excretion: Renal (90% within 24 hours)
Inclusive of all taxes
You Save: 0
Surat , India
Manufacturer, Contractor, Retailer, Brand Owner, Distributor, Exporter, Importer, Wholesaler, Startup
GST- 24abdfb4194j1ze
